Xeljanz Interactions
There are 659 drugs known to interact with Xeljanz (tofacitinib), along with 13 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 378 are major, 270 are moderate, and 11 are minor.
- View all 659 medications that may interact with Xeljanz
- View Xeljanz alcohol/food interactions (2)
- View Xeljanz disease interactions (13)
Most frequently checked interactions
View interaction reports for Xeljanz (tofacitinib) and the medicines listed below.
- albuterol
- amlodipine
- atorvastatin
- Cymbalta (duloxetine)
- doxycycline
- duloxetine
- folic acid
- gabapentin
- Humira (adalimumab)
- hydroxychloroquine
- leflunomide
- levothyroxine
- lisinopril
- losartan
- Lyrica (pregabalin)
- meloxicam
- metformin
- methotrexate
- montelukast
- omeprazole
- pantoprazole
- Plaquenil (hydroxychloroquine)
- prednisone
- tizanidine
- tramadol
- trazodone
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Zyrtec (cetirizine)
Xeljanz alcohol/food interactions
There are 2 alcohol/food interactions with Xeljanz (tofacitinib).
Xeljanz disease interactions
There are 13 disease interactions with Xeljanz (tofacitinib) which include:
- cardiovascular risk
- malignancy
- thrombosis
- infections
- tuberculosis
- viral reactivation
- cytopenias
- diabetes
- GI obstruction
- GI perforation
- hepatic disorder
- hyperlipidemia
- renal disease
Report options
QR code containing a link to this page
More about Xeljanz (tofacitinib)
- Xeljanz consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (145)
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: antirheumatics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
